Page last updated: 2024-12-06
soquinolol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
soquinolol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 68811 |
| CHEMBL ID | 1742453 |
| SCHEMBL ID | 844279 |
| MeSH ID | M0163280 |
Synonyms (21)
| Synonym |
|---|
| soquinolol [inn] |
| einecs 262-844-8 |
| 2(1h)-isoquinolinecarboxaldehyde, 3,4-dihydro-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)- |
| 5-(3-(tert-butylamino)-2-hydroxypropoxy)-3,4-dihydro-1h-isoquinoline-2-carbaldehyde |
| soquinolol |
| soquinololum [inn-latin] |
| 5-(3-(tert-butylamino)-2-hydroxypropoxy)-3,4-dihydro-2(1h)-isoquinolinecarboxaldehyde |
| 2-formyl-1,2,3,4-tetrahydro-5-(2-hydroxy-3-tert-butylaminopropoxy)isoquinoline |
| 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1h-isoquinoline-2-carbaldehyde |
| 61563-18-6 |
| CHEMBL1742453 |
| soquinololum |
| 15cc9boh7q , |
| unii-15cc9boh7q |
| soquinolol [who-dd] |
| SCHEMBL844279 |
| AKOS027381587 |
| DTXSID00866865 |
| 5-(3-(tert-butylamino)-2-hydroxypropoxy)-3,4-dihydroisoquinoline-2(1h)-carbaldehyde |
| 61563-18-6 (free base) |
| Q15633996 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " We detected a trend in mitogenic stimulation among LNCaP cells along the higher concentrations of the dose-response curve (0." | ( Immune function, mitogenicity, and angiogenic growth factor concentrations in lean and obese rodent sera: implications in obesity-related prostate tumor biology. Braverman, AS; Gerstein, MI; Harris, CF; Mydlo, JH, 2003) | 0.32 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.34
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.34) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||